Barclays PLC Eli Lilly & CO Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Barclays PLC holds 39,100 shares of LLY stock, worth $30.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,100

Previous 2,591,291 98.49%

Holding current value

$30.1 Million

Previous $1.51 Billion 97.99%

% of portfolio

0.01%

Previous 0.55%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $287 Million - $384 Million	-484,394 Reduced 18.69%	2,106,897 $1.64 Billion
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $277 Million - $326 Million	526,547 Added 25.5%	2,591,291 $1.51 Billion
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $239 Million - $329 Million	549,719 Added 36.28%	2,064,744 $1.11 Billion
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $318 Million - $425 Million	905,548 Added 148.58%	1,515,025 $711 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $283 Million - $332 Million	-909,465 Reduced 59.87%	609,477 $209 Million

Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $118 Million - $137 Million	366,307 Added 31.78%	1,518,942 $556 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $95.2 Million - $108 Million	320,937 Added 38.59%	1,152,635 $373 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $99.4 Million - $117 Million	-356,733 Reduced 30.02%	831,698 $270 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $372 Million - $462 Million	-1,583,991 Reduced 57.13%	1,188,431 $340 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $197 Million - $245 Million	877,346 Added 46.3%	2,772,422 $766 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $154 Million - $189 Million	693,851 Added 57.76%	1,895,076 $438 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $25.9 Million - $33.5 Million	143,363 Added 13.55%	1,201,225 $276 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $33.3 Million - $43.1 Million	202,620 Added 23.69%	1,057,862 $198 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $3.15 Million - $4.17 Million	24,139 Added 2.9%	855,242 $144 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $31.5 Million - $36.4 Million	215,157 Added 34.93%	831,103 $123 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $24.5 Million - $29.4 Million	-179,319 Reduced 22.55%	615,946 $101 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $66.8 Million - $82.6 Million	-560,737 Reduced 41.35%	795,265 $110 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $17 Million - $21 Million	-158,534 Reduced 10.47%	1,356,002 $178 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $11.1 Million - $12 Million	-103,660 Reduced 6.41%	1,514,536 $169 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $42.4 Million - $49.5 Million	382,464 Added 30.95%	1,618,196 $179 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $22.1 Million - $26.1 Million	198,970 Added 19.19%	1,235,732 $160 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $34.2 Million - $38.3 Million	-322,708 Reduced 23.74%	1,036,762 $120 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $7.24 Million - $9.05 Million	84,369 Added 6.62%	1,359,470 $146 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $20.2 Million - $23.2 Million	-267,103 Reduced 17.32%	1,275,101 $109 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $31.9 Million - $37.6 Million	429,605 Added 38.61%	1,542,204 $119 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $46 Million - $49.4 Million	561,514 Added 101.89%	1,112,599 $94 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $42.5 Million - $47.1 Million	551,085	551,085 $47.1 Million

Others Institutions Holding LLY

# of Institutions

3,703

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $732B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account